OTCMKTS:FUJIY

Fujifilm Q1 2026 Earnings Report

Fujifilm logo
$10.62 +0.16 (+1.53%)
As of 06/18/2026 03:59 PM Eastern

Fujifilm EPS Results

Actual EPS
$0.15
Consensus EPS
$0.15
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Fujifilm Revenue Results

Actual Revenue
$5.08 billion
Expected Revenue
$760.41 billion
Beat/Miss
Missed by -$755.33 billion
YoY Revenue Growth
N/A

Fujifilm Announcement Details

Quarter
Q1 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Fujifilm's next earnings date is estimated for Wednesday, August 5, 2026, based on past reporting schedules.

Conference Call Resources

Fujifilm Earnings Headlines

Fujifilm Life Sciences at BIO 2026
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
See More Fujifilm Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fujifilm? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fujifilm and other key companies, straight to your email.

About Fujifilm

Fujifilm (OTCMKTS:FUJIY) (OTCMKTS:FUJIY) is a Tokyo-based multinational conglomerate originally founded in 1934 as Fuji Photo Film Co., Ltd. Over the decades the company has evolved from a photographic film manufacturer into a diversified technology group operating across imaging, information, highly functional materials and healthcare. Fujifilm Holdings Corporation serves customers worldwide with a combination of hardware, consumables, software and services.

The company’s product and service portfolio spans consumer and professional imaging products, commercial and industrial printing systems, and office document solutions including printers and copiers. Fujifilm also develops and supplies highly functional materials and components used in electronics and manufacturing, such as specialty films, coatings and display materials. In healthcare and life sciences, the group offers diagnostic imaging systems, endoscopy equipment, in vitro diagnostics, and has a growing presence in pharmaceuticals and biopharmaceutical contract development and manufacturing.

Fujifilm conducts research and development through global R&D centers and operates manufacturing and sales networks across Asia, Europe, the Americas and other regions, supporting both local markets and international customers. The company’s strategy in recent years has emphasized diversification away from traditional photographic film into higher-growth areas such as medical technologies, bioprocessing services and advanced materials, leveraging its chemical and imaging expertise.

As a holdings group, Fujifilm is managed through an executive team based in Tokyo and a portfolio of operating subsidiaries that focus on specific markets and technologies. The company is known for technology-driven partnerships, investments in R&D and an ability to apply core competencies across consumer, industrial and healthcare sectors.

View Fujifilm Profile